NAT REV CARDIOL
| WoS 期刊 JCR 分区 (2026 · JIF) | 综合 SCIE | Q1 | ||
|---|---|---|---|---|
| 学科 | 收录集 | JIF 分区 | JIF 排名 | JIF 百分位 |
| 心脏与心血管系统 Cardiac & Cardiovascular Systems | SCIE | Q1 | 1/237 |
99.6%
|
| 学科 | 收录集 | JCI 分区 | JCI 排名 | JCI 百分位 |
|---|---|---|---|---|
| 心脏与心血管系统 Cardiac & Cardiovascular Systems | SCIE | Q1 | 3/199 JCI 7.04 |
99.0%
|
Nature Reviews Cardiology is a premier monthly journal published by Springer Nature, dedicated to providing authoritative and comprehensive coverage of the entire spectrum of cardiovascular medicine. With an ISSN of 1759-5002, the journal boasts an exceptional 2026 Impact Factor of 50.200, placing it firmly in the top Q1 quartile of the JCR, a testament to its profound influence and high citation within the field. The scope encompasses all major areas of cardiology, including ischemic heart disease, heart failure, arrhythmias, valvular disease, hypertension, vascular biology, and preventive cardiology, with a strong emphasis on translational research, clinical trials, and emerging therapies. Unlike traditional primary research journals, Nature Reviews Cardiology primarily publishes high-impact review articles, including comprehensive Reviews, topical Perspectives, and concise News & Views pieces that synthesize the latest advances and contextualize their clinical significance. It also features editorials, interviews, and research highlights that distill key findings from the broader literature. The target audience is broad and sophisticated, comprising academic researchers, clinical cardiologists, fellows, and healthcare professionals seeking a rigorous yet accessible synthesis of rapidly evolving knowledge. A notable feature is that the journal is subscription-based (not open access), though selected articles may be made freely available. Its standing as one of the highest-impact journals in cardiology, consistently ranking among the top titles globally, makes it an essential resource for staying at the forefront of cardiovascular science and clinical practice.